Doctors Note Logo

Published on: 8/18/2026

Understanding Neurosteroid Synthesis: How Adrenal Hormones Modulate Nociception

Adrenal hormones do more than manage stress, they supply the raw material for neurosteroids such as allopregnanolone and DHEA that can either dampen or amplify pain signaling in the brain and spinal cord. Cortisol, progesterone metabolites, and DHEA act on GABA-A, NMDA, and sigma-1 receptors, which means chronic stress, disrupted adrenal output, or shifting steroid levels can lower your pain threshold and intensify nociception. Several factors shape this pathway, including sleep quality, inflammation, sex hormones, age, and medication use, so see below to understand more before drawing conclusions about your own pain. Because hormone-linked pain sensitivity closely mimics many other conditions, from fibromyalgia to thyroid and autoimmune disorders, mapping your specific symptoms early is the fastest way to avoid a misleading self-diagnosis. Take a free, instant, online symptom check to see which possibilities fit your pattern and to get clear guidance on your next steps.

Last reviewed for medical accuracy: 08/18/2026

answer background

Explanation

Understanding Neurosteroid Synthesis: How Adrenal Hormones Modulate Nociception

Chronic fatigue and pain often go hand in hand, leaving many people searching for answers. Emerging research points to neurosteroids—hormones produced in the brain and adrenal glands—as key players in how our bodies perceive and manage pain. Two of these neurosteroids, dehydroepiandrosterone (DHEA) and pregnenolone, have drawn particular attention for their roles in chronic fatigue pain. This article explains how DHEA and pregnenolone are made, how they influence nociception (pain signaling), and what this might mean for those struggling with ongoing pain and fatigue.

  1. Adrenal Hormones and Neurosteroid Basics
    Our adrenal glands produce a cascade of hormones. Two critical precursors in this cascade are:
  • Pregnenolone
    • Often called the “mother” neurosteroid
    • Synthesized from cholesterol
    • Precedes production of all other steroid hormones, including DHEA, cortisol, progesterone and estrogen

  • Dehydroepiandrosterone (DHEA)
    • Produced downstream from pregnenolone
    • Circulates in the blood in both free and sulfated (DHEA-S) forms
    • Serves as a precursor for androgens (testosterone) and estrogens

These hormones not only regulate stress, metabolism and immune function, but also cross into the brain to become neurosteroids. There, they bind to receptors that influence neuronal excitability and pain pathways.

  1. Neurosteroid Synthesis Pathway
    In simplified terms, the pathway looks like this:

  2. Cholesterol → Pregnenolone

  3. Pregnenolone → Progesterone or 17-hydroxypregnenolone

  4. 17-hydroxypregnenolone → DHEA

  5. DHEA → Androgens → Estrogens

Key points:

  • Enzyme activity (e.g., CYP11A1, 3β-HSD) controls each step.
  • Stress, aging and inflammation can down-regulate these enzymes, lowering pregnenolone and DHEA levels.
  • Reduced substrate availability from cholesterol can also limit neurosteroid output.
  1. How Neurosteroids Modulate Nociception
    Neurosteroids influence pain perception via multiple mechanisms:

• GABA-A Receptor Modulation
– Pregnenolone derivatives enhance GABA (the main inhibitory neurotransmitter).
– Increased GABAergic tone can dampen pain signals in the spinal cord and brain.

• NMDA Receptor Interaction
– DHEA and pregnenolone can modulate NMDA (glutamate) receptors.
– By balancing excitatory signals, they prevent central sensitization (heightened pain response).

• Sigma-1 Receptor Binding
– Some neurosteroids bind sigma-1 receptors, which regulate calcium signaling and neuroinflammation.
– Proper sigma-1 function helps keep pain pathways from becoming overactive.

• Anti-inflammatory Effects
– DHEA has immunomodulatory properties, reducing pro-inflammatory cytokines (e.g., TNF-α, IL-6).
– Lower inflammation correlates with less peripheral and central pain sensitization.

  1. DHEA and Pregnenolone Levels in Chronic Fatigue Pain
    Multiple studies have found:
  • Patients with chronic fatigue syndrome (CFS) and fibromyalgia often show lower serum DHEA and pregnenolone levels than healthy controls.
  • Reduced DHEA-S correlates with higher pain scores and worse fatigue.
  • Low pregnenolone has been linked to cognitive fog, sleep disturbances and mood swings—common companions to chronic pain.

Why these deficiencies matter:

  • Diminished neurosteroid tone may fail to suppress pain pathways adequately.
  • Lower anti-inflammatory action allows ongoing immune activation, perpetuating pain and exhaustion cycles.
  • Imbalances in excitatory/inhibitory neurotransmission can contribute to central sensitization, making even light touch painful.
  1. Measuring and Supporting Neurosteroid Levels
    If you suspect low DHEA or pregnenolone:
  • Talk with your healthcare provider about testing serum DHEA-S and pregnenolone.
  • Be aware that normal ranges vary by age, sex and lab standards.
  • A comprehensive panel may also include cortisol, progesterone and sex hormones to spot broader endocrine imbalances.

Potential supportive strategies:

• Lifestyle Interventions
– Regular, moderate exercise (e.g., walking, yoga) to boost endogenous neurosteroid production.
– Stress reduction techniques (meditation, deep breathing) to normalize adrenal function.
– Quality sleep hygiene—adequate rest supports regeneration of neurosteroid pathways.

• Nutritional Support
– A balanced diet rich in healthy fats (omega-3s, monounsaturated fats) provides cholesterol for neurosteroid synthesis.
– Magnesium, zinc and B-vitamins serve as co-factors in hormone production.
– Avoid excessive caffeine and alcohol, which can impair adrenal health.

• Supplementation (under medical supervision)
– Pregnenolone and DHEA supplements exist, but dosing requires careful monitoring.
– Too much DHEA can convert to excess androgens or estrogens, leading to side effects (acne, hair changes, mood shifts).
– Work with an endocrinologist or integrative physician skilled in hormone replacement therapy.

  1. Integrating Neurosteroid Modulation into Pain Management
    Because chronic fatigue pain is multi-factorial, consider a combined approach:
  • Pharmacologic therapies (e.g., low-dose tricyclics, SNRIs) to manage pain and improve sleep.
  • Physical therapy and gentle movement programs to reduce stiffness and improve blood flow.
  • Cognitive-behavioral strategies to address pain-related anxiety and catastrophic thinking.
  • Neurosteroid support (lifestyle, nutritional, supplemental) to address underlying biochemical imbalances.
  1. When to Seek Professional Help
    Persistent, severe or worsening symptoms—especially if accompanied by unexplained weight loss, fevers, neurological deficits or mental health crises—require prompt medical evaluation. If you’re unsure where to start, you might consider doing a free, online symptom check, using the doctor approved Ubie Symptom Checker.

  2. Key Takeaways

  • Pregnenolone and DHEA are central neurosteroids produced by the adrenal glands and brain.
  • They modulate pain through GABA-A, NMDA and sigma-1 receptors, plus anti-inflammatory actions.
  • Low levels of DHEA and pregnenolone are common in chronic fatigue and pain syndromes.
  • Supporting neurosteroid synthesis involves lifestyle, nutritional, and—when needed—carefully monitored supplementation.
  • A multi-modal treatment plan that includes hormonal balance can help reduce pain sensitivity and improve overall well-being.

Before making any changes to your treatment plan or starting supplements, speak to a doctor—especially if you have serious or life-threatening conditions. Your healthcare provider can help interpret test results, guide safe dosing, and monitor for side effects. With the right combination of strategies, reclaiming your energy and reducing chronic pain is within reach.

(References)

  • * Maurice T. Neurosteroids and sigma1 receptors, biochemical and behavioral relevance. Pharmacopsychiatry. 2004 Nov;37 Suppl 3:S171-82. doi: 10.1055/s-2004-832675. PMID: 15547783.

  • * Rathbun KM, Singhal M. Addisonian Crisis(Archived). 2026 Jan. PMID: 28722962.

  • * Elshimy G, Chippa V, Kaur J, Jeong JM. Adrenal Crisis. 2026 Jan. PMID: 29763143.

  • * Meyer L, Taleb O, Patte-Mensah C, Mensah-Nyagan AG. Neurosteroids and neuropathic pain management: Basic evidence and therapeutic perspectives. Front Neuroendocrinol. 2019 Oct;55:100795. doi: 10.1016/j.yfrne.2019.100795. Epub 2019 Sep 25. PMID: 31562849.

  • * Held K, Tóth BI. TRPM3 in Brain (Patho)Physiology. Front Cell Dev Biol. 2021;9:635659. doi: 10.3389/fcell.2021.635659. Epub 2021 Feb 26. PMID: 33732703; PMCID: PMC7959729.

  • * Burglen L, Van Hoeymissen E, Qebibo L, Barth M, Belnap N, Boschann F, Depienne C, De Clercq K, Douglas AGL, Fitzgerald MP, Foulds N, Garel C, Helbig I, Held K, Horn D, Janssen A, Kaindl AM, Narayanan V, Prager C, Rupin-Mas M, Afenjar A, Zhao S, Ramaekers VT, Ruggiero SM, Thomas S, Valence S, Van Maldergem L, Rohacs T, Rodriguez D, Dyment D, Voets T, Vriens J. Gain-of-function variants in the ion channel gene TRPM3 underlie a spectrum of neurodevelopmental disorders. Elife. 2023 Jan 17;12. doi: 10.7554/eLife.81032. Epub 2023 Jan 17. PMID: 36648066; PMCID: PMC9886277.

  • * Marinelli S, Coccurello R. From the Gender Gap to Neuroactive Steroids: Exploring Multiple Cases to Further Understand Neuropathic Pain. Int J Mol Sci. 2023 May 11;24(10). doi: 10.3390/ijms24108577. Epub 2023 May 11. PMID: 37239924; PMCID: PMC10218318.

  • * Jevtovic-Todorovic V, Todorovic SM. The Role of Neuroactive Steroids in Analgesia and Anesthesia: An Interesting Comeback? Biomolecules. 2023 Nov 15;13(11). doi: 10.3390/biom13111654. Epub 2023 Nov 15. PMID: 38002336; PMCID: PMC10669813.

  • * Park GW, Kim H, Won SH, Kim NH, Choi SR. Neurosteroids and neurological disorders. Korean J Physiol Pharmacol. 2025 Mar 1;29(2):157-164. doi: 10.4196/kjpp.24.353. Epub 2025 Jan 14. PMID: 39806788; PMCID: PMC11842297.

  • * Yin Y, Park CG, Feng S, Guan Z, Lee HJ, Zhang F, Sharma K, Borgnia MJ, Im W, Lee SY. Molecular basis of neurosteroid and anticonvulsant regulation of TRPM3. Nat Struct Mol Biol. 2025 May;32(5):828-840. doi: 10.1038/s41594-024-01463-8. Epub 2025 Jan 14. PMID: 39809942; PMCID: PMC12086041.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.